These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 15606858)

  • 1. Dr J. Cabrera is the creator of the patented polidocanol microfoam.
    Cabrera J
    Dermatol Surg; 2004 Dec; 30(12 Pt 2):1605; author reply 1606. PubMed ID: 15606858
    [No Abstract]   [Full Text] [Related]  

  • 2. The VANISH-2 study: a randomized, blinded, multicenter study to evaluate the efficacy and safety of polidocanol endovenous microfoam 0.5% and 1.0% compared with placebo for the treatment of saphenofemoral junction incompetence.
    Todd KL; Wright DI;
    Phlebology; 2014 Oct; 29(9):608-18. PubMed ID: 23864535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ischaemic neurological deficit after sclerotherapy.
    Trenkwalder P; Lydtin H
    Lancet; 1994 Mar; 343(8900):794. PubMed ID: 7907752
    [No Abstract]   [Full Text] [Related]  

  • 4. Reversible ischaemic neurological deficit after sclerotherapy of varicose veins.
    Van der Plas JP; Lambers JC; Van Wersch JW; Koehler PJ
    Lancet; 1994 Feb; 343(8894):428. PubMed ID: 7905592
    [No Abstract]   [Full Text] [Related]  

  • 5. Stroke after varicose vein foam injection sclerotherapy.
    Forlee MV; Grouden M; Moore DJ; Shanik G
    J Vasc Surg; 2006 Jan; 43(1):162-4. PubMed ID: 16414404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Truncal Incompetence and Varicose Veins with a Single Administration of a New Polidocanol Endovenous Microfoam Preparation Improves Symptoms and Appearance.
    King JT; O'Byrne M; Vasquez M; Wright D;
    Eur J Vasc Endovasc Surg; 2015 Dec; 50(6):784-93. PubMed ID: 26384639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Migraine ophthalmique with reversible scotomas after sclerotherapy with liquid 1% polidocanol.
    Künzlberger B; Pieck C; Altmeyer P; Stücker M
    Dermatol Surg; 2006 Nov; 32(11):1410-3. PubMed ID: 17083597
    [No Abstract]   [Full Text] [Related]  

  • 8. Sclerotherapy: a study comparing polidocanol in foam and liquid form.
    Uncu H
    Phlebology; 2010 Feb; 25(1):44-9. PubMed ID: 20118346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous ultrasound-guided sclerotherapy with polidocanol microfoam for lymphatic malformations.
    Yamaki T; Sasaki Y; Hasegawa Y; Osada A; Konoeda H; Hamahata A; Nozaki M; Sakurai H
    J Vasc Surg Venous Lymphat Disord; 2017 Sep; 5(5):707-714. PubMed ID: 28818226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polidocanol (Varithena) for varicose veins.
    Med Lett Drugs Ther; 2015 Aug; 57(1474):111-2. PubMed ID: 26218793
    [No Abstract]   [Full Text] [Related]  

  • 11. Polidocanol: the perfect "solution".
    Weiss RA
    J Dermatol Surg Oncol; 1994 Jul; 20(7):465. PubMed ID: 8034841
    [No Abstract]   [Full Text] [Related]  

  • 12. Indications for the sclerosing agent polidocanol.
    Duffy DM
    J Dermatol Surg Oncol; 1994 Jul; 20(7):494-5. PubMed ID: 7661903
    [No Abstract]   [Full Text] [Related]  

  • 13. [Sclerotherapy of idiopatic hydrocele with polidocanol: a study about 190 cases].
    Sallami S; Binous MY; Ben Rhouma S; Chelif M; Hmidi M; Nouira Y; Ben Rais N; Horchani A
    Tunis Med; 2011 May; 89(5):440-4. PubMed ID: 21557180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Embolia cutis medicamentosa of the foot after sclerotherapy.
    Geukens J; Rabe E; Bieber T
    Eur J Dermatol; 1999 Mar; 9(2):132-3. PubMed ID: 10066964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The French polidocanol study on long-term side effects: a survey covering 3,357 patient years.
    Guex JJ; Schliephake DE; Otto J; Mako S; Allaert FA
    Dermatol Surg; 2010 Jun; 36 Suppl 2():993-1003. PubMed ID: 20590706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localized retiform purpura after accidental intra-arterial injection of polidocanol.
    Yébenes M; Gilaberte M; Toll A; Barranco C; Pujol RM
    Acta Derm Venereol; 2005; 85(4):372-3. PubMed ID: 16191871
    [No Abstract]   [Full Text] [Related]  

  • 17. Benefits of polidocanol endovenous microfoam (Varithena®) compared with physician-compounded foams.
    Carugo D; Ankrett DN; Zhao X; Zhang X; Hill M; O'Byrne V; Hoad J; Arif M; Wright DD; Lewis AL
    Phlebology; 2016 May; 31(4):283-95. PubMed ID: 26036246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. More on hypertrichosis after sclerotherapy.
    Kiripolsky MG
    Dermatol Surg; 2010 Jun; 36 Suppl 2():1066-7. PubMed ID: 20590715
    [No Abstract]   [Full Text] [Related]  

  • 19. Regarding "Stroke after varicose vein foam injection sclerotherapy".
    Eckmann DM; Kobayashi S
    J Vasc Surg; 2006 Jul; 44(1):225; author reply 225-6. PubMed ID: 16828455
    [No Abstract]   [Full Text] [Related]  

  • 20. [Anaphylaxis following use of polidocanol].
    Stricker BH; van Oijen JA; Kroon C; Ovink AH
    Ned Tijdschr Geneeskd; 1990 Feb; 134(5):240-2. PubMed ID: 2304580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.